B2G Life Sciences is a science-driven, international, medical consulting company, dedicated to clinical development.
They serve as acting CMO, yet also provide extended stand-alone as well as fully-integrated services, to the biotechnology and pharmaceutical industry, with a particular focus on rare and orphan diseases, oncology, as well as biotherapies and advanced therapies.

They have operational capacities across Europe and the Mediterranean region, as we endeavor to build bridges and gateways between operators in different markets.

They serve as acting CMO and provide extended stand-alone as well as fully-integrated consulting services to the biotechnology and pharmaceutical industry, with a particular focus on rare and orphan diseases, oncology,
as well as biotherapeutics and advances therapies.

From study design to execution, they provide services in the following focus areas:
– Clinical development strategies and protocol development
– Management of scientific boards
– Study conduct and patient enrollment
– Medical review and medical writing
– Trainings in the busnisses of biotech and pharma industries.

–  Therapeutic areas: Clinical Development Consulting services, Rare diseases, Oncology, Biotherapies, Advanced therapies

–  Based in: Sèvres (FRANCE)

–  Employees: 11 – 50

–  Created in: 2011